A revolution in the treatment of non-Hodgkin's lymphoma

被引：29

作者：

DeNardo, GL

O'Donnell, RT

Oldham, RK

DeNardo, SJ

机构：

[1] Univ Calif Davis, Sch Med, Dept Internal Med, Sacramento, CA 95618 USA

[2] Biol Therapy Inst, Franklin, TN USA

来源：

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS | 1998年 / 13卷 / 04期

关键词：

D O I：

10.1089/cbr.1998.13.213

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The use of monoclonal antibodies (MoAbs)for immunotherapy and radioimmunotherapy has ushered in a new era in the treatment of non-Hodgkin's lymphoma.

引用

页码：213 / 223

页数：11

共 65 条

[1] RADIOIMMUNOTHERAPY OF HUMAN-COLON CARCINOMA BY I-131-LABELED MONOCLONAL ANTI-CEA ANTIBODIES IN A NUDE-MOUSE MODEL [J].

BUCHEGGER, F ;

VACCA, A ;

CARREL, S ;

SCHREYER, M ;

MACH, JP .

INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (01) :127-134

[2]

BUCHSBAUM D, 1995, CANCER RES, V55, pS5881

[3] PHASE-I DOSE-ESCALATION TRIAL OF IODINE 131-LABELED MONOCLONAL-ANTIBODY OKB7 IN PATIENTS WITH NON-HODGKINS-LYMPHOMA [J].

CZUCZMAN, MS ;

STRAUS, DJ ;

DIVGI, CR ;

GRAHAM, M ;

GARINCHESA, P ;

FINN, R ;

MYERS, J ;

OLD, LJ ;

LARSON, SM ;

SCHEINBERG, DA .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (10) :2021-2029

[4] Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs [J].

Demidem, A ;

Lam, T ;

Alas, S ;

Hariharan, K ;

Hanna, N ;

Bonavida, B .

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1997, 12 (03) :177-186

[5]

DENARDO GL, 1990, CANCER RES, V50, pS1014

[6]

DENARDO GL, 1994, CANCER-AM CANCER SOC, V73, P1425, DOI 10.1002/1097-0142(19940301)73:5<1425::AID-CNCR2820730517>3.0.CO

[7]

2-D

[8]

DeNardo GL, 1997, CLIN CANCER RES, V3, P71

[9]

DeNardo GL, 1997, CANCER, V80, P2706, DOI 10.1002/(SICI)1097-0142(19971215)80:12+<2706::AID-CNCR49>3.0.CO

[10]

2-D

← 1 2 3 4 5 6 7 →